These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12407632)

  • 1. Preventing bacterial infections and antimicrobial resistance in dialysis patients.
    Berns JS; Tokars JI
    Am J Kidney Dis; 2002 Nov; 40(5):886-98. PubMed ID: 12407632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why is an infection control program needed in the hemodialysis setting?
    Arduino MJ; Tokars JI
    Nephrol News Issues; 2005 Jun; 19(7):44, 46-9. PubMed ID: 16008023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing antimicrobial therapy for gram-positive bloodstream infections in patients on hemodialysis.
    Pai AB; Pai MP
    Adv Chronic Kidney Dis; 2006 Jul; 13(3):259-70. PubMed ID: 16815231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National surveillance of dialysis-associated diseases in the United States, 2002.
    Finelli L; Miller JT; Tokars JI; Alter MJ; Arduino MJ
    Semin Dial; 2005; 18(1):52-61. PubMed ID: 15663766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance in gram-positive bacteria.
    Rice LB
    Am J Med; 2006 Jun; 119(6 Suppl 1):S11-9; discussion S62-70. PubMed ID: 16735146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterococcal resistance--an overview.
    Marothi YA; Agnihotri H; Dubey D
    Indian J Med Microbiol; 2005 Oct; 23(4):214-9. PubMed ID: 16327115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance in common pathogens reinforces the need to minimise surgical site infections.
    Dohmen PM
    J Hosp Infect; 2008 Nov; 70 Suppl 2():15-20. PubMed ID: 19022117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.
    Weber SG; Huang SS; Oriola S; Huskins WC; Noskin GA; Harriman K; Olmsted RN; Bonten M; Lundstrom T; Climo MW; Roghmann MC; Murphy CL; Karchmer TB
    Am J Infect Control; 2007 Mar; 35(2):73-85. PubMed ID: 17327185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of vancomycin-resistant enterococcus in health care facilities in a region.
    Ostrowsky BE; Trick WE; Sohn AH; Quirk SB; Holt S; Carson LA; Hill BC; Arduino MJ; Kuehnert MJ; Jarvis WR
    N Engl J Med; 2001 May; 344(19):1427-33. PubMed ID: 11346807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gram-positive bacterial infections resistant to antibiotic treatment].
    Utili R
    Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic-resistant organisms in the neonatal intensive care unit.
    Bizzarro MJ; Gallagher PG
    Semin Perinatol; 2007 Feb; 31(1):26-32. PubMed ID: 17317424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of routine glove use and contact-isolation precautions to prevent transmission of multidrug-resistant bacteria in a long-term care facility.
    Trick WE; Weinstein RA; DeMarais PL; Tomaska W; Nathan C; McAllister SK; Hageman JC; Rice TW; Westbrook G; Jarvis WR
    J Am Geriatr Soc; 2004 Dec; 52(12):2003-9. PubMed ID: 15571534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial use and stewardship programs among dialysis centers.
    D'Agata EM
    Semin Dial; 2013; 26(4):457-64. PubMed ID: 23600755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
    Fraise AP
    J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic burden of antimicrobial resistance.
    Maragakis LL; Perencevich EN; Cosgrove SE
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):751-63. PubMed ID: 18847410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistant enterococci: a threat to the surgical patient.
    Low DE; Willey BM; McGeer AJ
    Am J Surg; 1995 May; 169(5A Suppl):8S-12S. PubMed ID: 7755167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.
    Henderson DK
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S46-54: discussion S64-73. PubMed ID: 16813982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Orrett FA
    Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
    Garrison MW; Neumiller JJ; Setter SM
    Clin Ther; 2005 Jan; 27(1):12-22. PubMed ID: 15763603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program.
    Anderegg TR; Sader HS; Fritsche TR; Ross JE; Jones RN
    Int J Antimicrob Agents; 2005 Jul; 26(1):13-21. PubMed ID: 15967640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.